NIH Funding · FY2024
Total Funding
$1.9M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#5,668
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $1.9M across 2 grants · National rank #5668.
Top grants by award amount
Mark K Slifka's NIH grant portfolio, ranked by award amount.
- 4U44AI152995-02U44A Randomized Phase I Clinical Trial of HydroVax-CHIKV, a Novel Inactivated Chikungunya Virus Vaccine$986.1Kaward amount
- 5R01DK132225-02R01Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease$951.4Kaward amount
Affiliations
Institutions that have administered grants for Mark K Slifka.
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardNajit Technologies, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5668
- 2024Multi-Institutional ResearchAwards at 2 institutions
Related investigators
Other NIH-funded PIs frequently associated with Mark K Slifka.
Explore further
Find collaborators for Mark K Slifka
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Najit Technologies, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →